Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient setting

Published:2018-11 Issue:4 Volume:66 Page:95-101
ISSN:2452-3186
Container-title:Current Research in Translational Medicine
language:en
Short-container-title:Current Research in Translational Medicine

Author:

Hakimi Z.,Ferchichi S.,Aballea S.,Odeyemi I.,Toumi M.,English M.,Yakoub-Agha I.

Funder

Astellas Pharma Global Development, Inc

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference39 articles.

1. Overview: cytomegalovirus and the herpesviruses in transplantation;Fishman;Am J Transplant,2013

2. Valacyclovir for the prevention of cytomegalovirus infection after allogeneic stem cell transplantation: a single institution retrospective cohort analysis;Vusirikala;Bone Marrow Transplant,2001

3. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial;Boeckh;Ann Intern Med,2015

4. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation;Chemaly;N Engl J Med,2014

5. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial;Marty;Lancet Infect Dis,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost‐effectiveness of maribavir versus conventional antiviral therapies for post‐transplant refractory cytomegalovirus infection with or without genotypic resistance: A US perspective;Journal of Medical Virology;2024-04

2. [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy];Farmeconomia. Health economics and therapeutic pathways;2023-12-07

3. Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program;Journal of Clinical Virology;2022-03

4. Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study;Bone Marrow Transplantation;2020-12-18

5. Clinical and economic impact of treated CMV infection in adult CMV‐seropositive patients after allogeneic hematopoietic cell transplantation;Journal of Medical Virology;2020-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3